Status:
UNKNOWN
Prediction of Mortality in Patients Waiting for Liver Transplantation Through Brain Magnetic Resonance Imaging
Lead Sponsor:
Hospital Israelita Albert Einstein
Conditions:
End Stage Liver Disease
Hepatic Encephalopathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine whether hepatic encephalopathy, measured through magnetic resonance imaging, electroencephalogram and neuropsychological evaluation adds prognostic informatio...
Detailed Description
The only current definitive treatment for end-stage liver disease is transplantation. Due to the scarcity of organs available, the correct prioritization of patients for liver transplantation has a cr...
Eligibility Criteria
Inclusion
- Man or woman over 18 years old
- Listed in liver transplantation waiting line
- Patient able and willing to participate in the evaluations of this study
Exclusion
- Acute liver failure
- Serious structural brain anomalies
- Condition or situation in which, in the opinion of the investigator, put the patient at significant risk
Key Trial Info
Start Date :
November 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2015
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT01434056
Start Date
November 1 2011
End Date
February 1 2015
Last Update
September 14 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Israelita Albert Einstein
São Paulo, São Paulo, Brazil, 05652901